The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up

Czech version

Authors: C. W. Lees; A. I. Ali; A. I. Thompson; G. T. Ho; R. O. Forsythe; L. Marquez; C. J. Cochrane; S. Aitken; J. Fennell; P. Rogers; A. G. Shand; I. D. Penman; K. R. Palmer; D. C. Wilson; I. D. Arnott; J. Satsangi
Published in: Čas. Lék. čes. 2009; 148: 184
Category: Selected Abstract

Sources

Aliment Pharmacol Ther 2009; 29(3): 286–297.

Labels

Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist

Malignant melanoma: standards and innovation in diagnostics and therapy

Formation of the vascular bed: a review of its molecular mechanisms and therapeutic implications

Mirizzi syndrome with cholecystoduodenal fistula – a rare complication of cholecyctolithiasis

Bloodless medicine

Treatment of marijuana dependence

The first Obesity Unit in Czechoslovakia was established twenty years ago

Immune response to influenza vaccine in children with inflammatory bowel disease

Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis

Article was published in

Journal of Czech Physicians

2009 Issue 4

Download issue PDF